Financials Mytrex Health Technologies, Inc.

Equities

4431

TW0004431002

Textiles & Leather Goods

End-of-day quote Taipei Exchange 03:30:00 10/05/2024 am IST 5-day change 1st Jan Change
28.05 TWD -0.18% Intraday chart for Mytrex Health Technologies, Inc. -0.18% -9.81%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 403.4 307.6 1,805 1,003 924.3 1,136
Enterprise Value (EV) 1 329 188.2 1,210 586.2 576.6 1,146
P/E ratio 37.8 x 33.1 x 4.61 x -71.6 x -10.1 x -20.2 x
Yield 1.25% 1.34% 6.75% - - -
Capitalization / Revenue 0.83 x 0.77 x 1.76 x 3.44 x 3.97 x 0.88 x
EV / Revenue 0.68 x 0.47 x 1.18 x 2.01 x 2.47 x 0.89 x
EV / EBITDA 10.5 x 7.19 x 2.63 x 24.8 x -22 x 246 x
EV / FCF -11.7 x 4.43 x 6.87 x -116 x -34 x -62.2 x
FCF Yield -8.57% 22.6% 14.5% -0.87% -2.94% -1.61%
Price to Book 1.23 x 0.92 x 1.86 x 1.2 x 1.27 x 1.68 x
Nbr of stocks (in thousands) 31,586 31,586 36,536 36,536 36,536 36,536
Reference price 2 12.77 9.739 49.40 27.45 25.30 31.10
Announcement Date 29/04/19 27/04/20 01/04/21 31/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 486.4 398.4 1,024 291.6 233.1 1,293
EBITDA 1 31.2 26.18 460 23.65 -26.17 4.65
EBIT 1 15.44 10.58 438.1 -15.46 -65.39 -71.83
Operating Margin 3.17% 2.66% 42.8% -5.3% -28.06% -5.56%
Earnings before Tax (EBT) 1 12.53 6.339 441.1 -13.6 -91.81 -57.18
Net income 1 10.66 9.318 352.3 -14.01 -91.9 -56.22
Net margin 2.19% 2.34% 34.41% -4.8% -39.43% -4.35%
EPS 2 0.3375 0.2941 10.71 -0.3835 -2.515 -1.539
Free Cash Flow 1 -28.2 42.49 176 -5.073 -16.95 -18.41
FCF margin -5.8% 10.67% 17.19% -1.74% -7.27% -1.42%
FCF Conversion (EBITDA) - 162.35% 38.25% - - -
FCF Conversion (Net income) - 456.05% 49.95% - - -
Dividend per Share 2 0.1594 0.1307 3.333 - - -
Announcement Date 29/04/19 27/04/20 01/04/21 31/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 9.93
Net Cash position 1 74.4 119 595 417 348 -
Leverage (Debt/EBITDA) - - - - - 2.134 x
Free Cash Flow 1 -28.2 42.5 176 -5.07 -17 -18.4
ROE (net income / shareholders' equity) 2.89% 2.39% 53.8% -1.55% -11.8% -7.09%
ROA (Net income/ Total Assets) 2.15% 1.54% 31.6% -0.85% -4.57% -3.27%
Assets 1 496.9 606.8 1,115 1,653 2,012 1,720
Book Value Per Share 2 10.40 10.50 26.60 22.80 20.00 18.50
Cash Flow per Share 2 3.880 4.760 20.10 12.90 11.10 5.980
Capex 1 28.1 9.66 188 29.7 31.8 21.8
Capex / Sales 5.78% 2.43% 18.37% 10.2% 13.64% 1.68%
Announcement Date 29/04/19 27/04/20 01/04/21 31/03/22 31/03/23 26/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 4431 Stock
  4. Financials Mytrex Health Technologies, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW